Validity and Reliability Study of the Turkish Adaptation of the Reproductive Concerns After Cancer Scale

Makaleler > Tam Makale · 2026

Yazarlar: Ruken YAĞIZ ALTINTAŞ, Oya KAVLAK

INTERNATIONAL JOURNAL OF NURSING PRACTICE, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Social Sciences Citation Index, 2026, cilt 32, ss 1-9

Özet

<p>Objective:&nbsp;This&nbsp;methodological&nbsp;study&nbsp;aimed&nbsp;to&nbsp;evaluate&nbsp;the&nbsp;validity&nbsp;and&nbsp;reliability&nbsp;of&nbsp;the&nbsp;Turkish&nbsp;version&nbsp;of&nbsp;the&nbsp;ReproductiveConcerns&nbsp;After&nbsp;Cancer&nbsp;Scale.Method:&nbsp;The&nbsp;study&nbsp;included&nbsp;301&nbsp;women&nbsp;aged&nbsp;18–45&nbsp;diagnosed&nbsp;with&nbsp;cancer&nbsp;in&nbsp;Izmir,&nbsp;Turkey.&nbsp;The&nbsp;language&nbsp;validity&nbsp;was&nbsp;estab-lished&nbsp;through&nbsp;the&nbsp;translation–back-translation.&nbsp;Construct&nbsp;validity&nbsp;was&nbsp;assessed&nbsp;via&nbsp;exploratory&nbsp;factor&nbsp;analysis&nbsp;and&nbsp;confirma-tory&nbsp;factor&nbsp;analysis.&nbsp;Reliability&nbsp;was&nbsp;evaluated&nbsp;using&nbsp;internal&nbsp;consistency&nbsp;coefficients&nbsp;and&nbsp;test–retest&nbsp;analysis.Results:&nbsp;The&nbsp;Content&nbsp;Validity&nbsp;Index&nbsp;was&nbsp;0.90.&nbsp;Exploratory&nbsp;factor&nbsp;analysis&nbsp;identified&nbsp;a&nbsp;four-factor&nbsp;structure&nbsp;explaining&nbsp;67.88%&nbsp;ofthe&nbsp;total&nbsp;variance&nbsp;(KMO&nbsp;=&nbsp;0.87,&nbsp;p&nbsp;&lt;&nbsp;0.001).&nbsp;Confirmatory&nbsp;factor&nbsp;analysis&nbsp;confirmed&nbsp;this&nbsp;structure&nbsp;with&nbsp;acceptable&nbsp;fit&nbsp;indices&nbsp;(X2/df&nbsp;=&nbsp;3.34,&nbsp;RMSEA&nbsp;=&nbsp;0.07,&nbsp;CFI&nbsp;=&nbsp;0.90).&nbsp;The&nbsp;total&nbsp;Cronbach&#39;s&nbsp;alpha&nbsp;was&nbsp;0.88,&nbsp;with&nbsp;subscales&nbsp;ranging&nbsp;from&nbsp;0.75&nbsp;to&nbsp;0.90.&nbsp;Test–retestreliability&nbsp;was&nbsp;high&nbsp;(ICC&nbsp;=&nbsp;0.99).&nbsp;Item-total&nbsp;correlations&nbsp;ranged&nbsp;from&nbsp;0.31&nbsp;to&nbsp;0.72.Conclusions:&nbsp;The&nbsp;Turkish&nbsp;version&nbsp;of&nbsp;the&nbsp;Reproductive&nbsp;Concerns&nbsp;After&nbsp;Cancer&nbsp;Scale&nbsp;is&nbsp;a&nbsp;valid&nbsp;and&nbsp;reliable&nbsp;18-item&nbsp;tool.&nbsp;Oncologynurses&nbsp;can&nbsp;utilize&nbsp;this&nbsp;scale&nbsp;to&nbsp;effectively&nbsp;assess&nbsp;reproductive&nbsp;concerns&nbsp;in&nbsp;women&nbsp;of&nbsp;reproductive&nbsp;age,&nbsp;guiding&nbsp;counselling&nbsp;andsupportive&nbsp;care&nbsp;interventions.1&nbsp;|&nbsp;IntroductionIn&nbsp;recent&nbsp;years,&nbsp;there&nbsp;have&nbsp;been&nbsp;positive&nbsp;developments&nbsp;in&nbsp;cancertreatment,&nbsp;significantly&nbsp;improving&nbsp;survival&nbsp;rates&nbsp;post-treatment(Gucluel&nbsp;and&nbsp;Can&nbsp;2023).&nbsp;Worldwide,&nbsp;it&nbsp;is&nbsp;estimated&nbsp;that&nbsp;thereare&nbsp;53.5&nbsp;million&nbsp;total&nbsp;cancer&nbsp;patients&nbsp;alive&nbsp;within&nbsp;5&nbsp;years&nbsp;of&nbsp;di-agnosis,&nbsp;with&nbsp;27.7&nbsp;million&nbsp;being&nbsp;women&nbsp;(International&nbsp;Agencyfor&nbsp;Research&nbsp;on&nbsp;Cancer&nbsp;(GLOBOCAN)&nbsp;2022).&nbsp;In&nbsp;Turkey,&nbsp;thereare&nbsp;reported&nbsp;679.3&nbsp;thousand&nbsp;cases&nbsp;of&nbsp;cancer,&nbsp;with&nbsp;341.3&nbsp;thou-sand&nbsp;being&nbsp;women&nbsp;(International&nbsp;Agency&nbsp;for&nbsp;Research&nbsp;onCancer&nbsp;(GLOBOCAN)&nbsp;2022).&nbsp;When&nbsp;looking&nbsp;at&nbsp;the&nbsp;ratios,&nbsp;it&nbsp;isobserved&nbsp;that&nbsp;half&nbsp;of&nbsp;the&nbsp;individuals&nbsp;diagnosed&nbsp;with&nbsp;cancer&nbsp;arewomen.&nbsp;This&nbsp;further&nbsp;complicates&nbsp;the&nbsp;already&nbsp;stressful&nbsp;processof&nbsp;cancer&nbsp;diagnosis.&nbsp;Considering&nbsp;the&nbsp;increasing&nbsp;prevalence&nbsp;ofadvanced&nbsp;maternal-age&nbsp;pregnancies&nbsp;in&nbsp;developed&nbsp;countries,&nbsp;itis&nbsp;anticipated&nbsp;that&nbsp;some&nbsp;women&nbsp;diagnosed&nbsp;with&nbsp;cancer&nbsp;duringtheir&nbsp;reproductive&nbsp;years&nbsp;may&nbsp;not&nbsp;have&nbsp;yet&nbsp;initiated&nbsp;or&nbsp;completedtheir&nbsp;family&nbsp;planning.&nbsp;In&nbsp;cancer&nbsp;treatment&nbsp;processes,&nbsp;the&nbsp;use&nbsp;ofchemotherapy,&nbsp;radiation,&nbsp;surgery&nbsp;or&nbsp;hormonal&nbsp;therapy&nbsp;methodsmay&nbsp;damage&nbsp;reproductive&nbsp;organs&nbsp;(Waimey&nbsp;et&nbsp;al.&nbsp;2015).With&nbsp;the&nbsp;advancement&nbsp;of&nbsp;technology,&nbsp;various&nbsp;treatment&nbsp;op-tions&nbsp;have&nbsp;been&nbsp;introduced&nbsp;to&nbsp;combat&nbsp;the&nbsp;increasing&nbsp;incidenceof&nbsp;cancer,&nbsp;leading&nbsp;to&nbsp;a&nbsp;decrease&nbsp;in&nbsp;mortality&nbsp;rates.&nbsp;However,women&nbsp;exposed&nbsp;to&nbsp;gonadotoxic&nbsp;treatments&nbsp;such&nbsp;as&nbsp;chemother-apy&nbsp;and&nbsp;radiotherapy&nbsp;may&nbsp;experience&nbsp;a&nbsp;decrease&nbsp;in&nbsp;ovarianreserve&nbsp;and&nbsp;premature&nbsp;ovarian&nbsp;insufficiency.&nbsp;Interruption&nbsp;ofthe&nbsp;development&nbsp;process&nbsp;of&nbsp;germ&nbsp;cells,&nbsp;failure&nbsp;of&nbsp;the&nbsp;normalproliferation&nbsp;cycle,&nbsp;inadequacy&nbsp;in&nbsp;uterine&nbsp;muscle&nbsp;structure&nbsp;andblood&nbsp;circulation&nbsp;and&nbsp;alteration&nbsp;in&nbsp;the&nbsp;structure&nbsp;of&nbsp;oocytes&nbsp;due©&nbsp;2026&nbsp;John&nbsp;Wiley&nbsp;&amp;&nbsp;Sons&nbsp;Australia,&nbsp;Ltd.This&nbsp;study&nbsp;was&nbsp;presented&nbsp;as&nbsp;an&nbsp;oral&nbsp;presentation&nbsp;at&nbsp;the&nbsp;3rd&nbsp;International&nbsp;and&nbsp;4th&nbsp;National&nbsp;Women&#39;s&nbsp;Health&nbsp;Nursing&nbsp;Congress&nbsp;held&nbsp;in&nbsp;Istanbul,&nbsp;Turkey,&nbsp;in&nbsp;2025.</p>

Detay görüntüle